Press Releases Invion Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:17 2024-06-04 am EDT			5-day change	1st Jan Change
0.005 ^AUD	0.00%		+25.00%	0.00%

May. 08	Invion Partners with Hanlim Pharma for Glioblastoma Treatment	MT
Mar. 05	Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results	MT

Invion : Activities Report and Appendix 4C	22-07-20	PU
Invion : Notification regarding unquoted securities - IVX	22-06-19	PU
Invion : Activities Report and Appendix 4C	22-04-20	PU
Invion : Notification regarding unquoted securities - IVX	22-03-20	PU
Invion : Notice of General Meeting/Proxy Form	22-02-24	PU
Invion : Investor Presentation	22-02-02	PU
Invion : Application for quotation of securities - IVX	22-02-01	PU
Invion : Activities Report and Appendix 4C	22-01-19	PU
Invion : Application for quotation of securities - IVX	21-12-12	PU
Invion : Notification regarding unquoted securities - IVX	21-12-06	PU
Invion : Proposed issue of securities - IVX	21-11-25	PU
Invion : Cancel - Proposed issue of securities - IVX	21-11-23	PU
Invion : Proposed issue of securities - IVX	21-11-22	PU
Invion : Prospectus	21-11-22	PU
Invion : Share Purchase Plan Offer Booklet & Application Form	21-11-21	PU
Invion : Application for quotation of securities - IVX	21-11-21	PU
Invion : Proposed issue of securities - IVX	21-11-15	PU
Invion : selects Guilin Xingda to manufacture light-therapy medical equipment	19-01-29	PU
Invion : Collaborates to Develop Powerful Skin Cancer Gel	18-11-06	PU
Invion : spin-off Chronic Airway Therapeutics selects leading CRO for the future development of nadolol	18-09-26	PU

No results for this search